FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000516832> ?p ?o ?g. }

• W3000516832 endingPage "311" @default.
• W3000516832 startingPage "303" @default.
• W3000516832 abstract "Abstract Objective To compare the effects of (a) tibolone, (b) continuous combined oestrogen plus progestogen and (c) placebo on plasma lipid and lipoprotein markers of cardiovascular risk in healthy postmenopausal women. Study design Randomized, single‐centre, placebo‐controlled, double‐blind study. Patients One hundred and one postmenopausal women were randomized (1:1:1) into one of three groups taking daily 2.5 mg tibolone, continuous oral oestradiol‐17β 2 mg plus norethisterone acetate 1 mg daily (E 2 /NETA) or placebo. Main outcome measures Fasting serum lipid, lipoprotein and apolipoprotein concentrations measured at baseline and after 6, 12 and 24 months of treatment. Results Both tibolone and E 2 /NETA lowered plasma total cholesterol concentrations relative to placebo. With tibolone, high‐density lipoprotein cholesterol (HDL‐C) was reduced (−27% at 24 months, P < .001), the greatest effect being in the cholesterol‐enriched HDL 2 subfraction (−40%, P < .001). Tibolone's effect on HDL concentrations was also apparent in the principal HDL protein component, apolipoprotein AI (−29% at 24 months, P < .001). However, there was no significant effect of tibolone on low‐density or very low‐density lipoprotein cholesterol (LDL‐C and VLDL‐C, respectively). By contrast, the greatest reduction in cholesterol with E 2 /NETA was in LDL‐C (−22% at 24 months, P = .008). E 2 /NETA reduced HDL‐C to a lesser extent than tibolone (−12% at 24 months, P < .001). Effects on HDL apolipoproteins were similarly diminished relative to tibolone. E 2 /NETA had no effect on VLDL‐C or on the protein component of LDL, apolipoprotein B. Conclusion Tibolone reduces serum HDL. E 2 /NETA reduces LDL cholesterol but not apolipoprotein B, suggesting decreased cholesterol loading of LDL. Any impact these changes may have on CVD risk needs further investigation." @default.
• W3000516832 created "2020-01-23" @default.
• W3000516832 creator A5012225810 @default.
• W3000516832 creator A5069706403 @default.
• W3000516832 creator A5072708536 @default.
• W3000516832 creator A5088981741 @default.
• W3000516832 date "2020-01-28" @default.
• W3000516832 modified "2023-09-27" @default.
• W3000516832 title "Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high‐density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two‐year, randomized, double‐blind, placebo‐controlled trial" @default.
• W3000516832 cites W1844308307 @default.
• W3000516832 cites W1970351209 @default.
• W3000516832 cites W1987144846 @default.
• W3000516832 cites W1990207743 @default.
• W3000516832 cites W1990958017 @default.
• W3000516832 cites W1994185573 @default.
• W3000516832 cites W2012974823 @default.
• W3000516832 cites W2020796252 @default.
• W3000516832 cites W2042440802 @default.
• W3000516832 cites W2054376446 @default.
• W3000516832 cites W2054391347 @default.
• W3000516832 cites W2068759952 @default.
• W3000516832 cites W2078535669 @default.
• W3000516832 cites W2081124974 @default.
• W3000516832 cites W2083058051 @default.
• W3000516832 cites W2083128744 @default.
• W3000516832 cites W2088416370 @default.
• W3000516832 cites W2089358310 @default.
• W3000516832 cites W2092077970 @default.
• W3000516832 cites W2092407540 @default.
• W3000516832 cites W2095897929 @default.
• W3000516832 cites W2101594273 @default.
• W3000516832 cites W2116404316 @default.
• W3000516832 cites W2116606813 @default.
• W3000516832 cites W2144644927 @default.
• W3000516832 cites W2154747636 @default.
• W3000516832 cites W2159140695 @default.
• W3000516832 cites W2189623052 @default.
• W3000516832 doi "https://doi.org/10.1111/cen.14155" @default.
• W3000516832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31925799" @default.
• W3000516832 hasPublicationYear "2020" @default.
• W3000516832 type Work @default.
• W3000516832 sameAs 3000516832 @default.
• W3000516832 citedByCount "5" @default.
• W3000516832 countsByYear W30005168322021 @default.
• W3000516832 countsByYear W30005168322022 @default.
• W3000516832 countsByYear W30005168322023 @default.
• W3000516832 crossrefType "journal-article" @default.
• W3000516832 hasAuthorship W3000516832A5012225810 @default.
• W3000516832 hasAuthorship W3000516832A5069706403 @default.
• W3000516832 hasAuthorship W3000516832A5072708536 @default.
• W3000516832 hasAuthorship W3000516832A5088981741 @default.
• W3000516832 hasBestOaLocation W30005168322 @default.
• W3000516832 hasConcept C126322002 @default.
• W3000516832 hasConcept C134018914 @default.
• W3000516832 hasConcept C142724271 @default.
• W3000516832 hasConcept C204787440 @default.
• W3000516832 hasConcept C27081682 @default.
• W3000516832 hasConcept C2777457466 @default.
• W3000516832 hasConcept C2778163477 @default.
• W3000516832 hasConcept C2778562196 @default.
• W3000516832 hasConcept C2780072125 @default.
• W3000516832 hasConcept C2780541478 @default.
• W3000516832 hasConcept C2780835420 @default.
• W3000516832 hasConcept C2781039349 @default.
• W3000516832 hasConcept C2908647359 @default.
• W3000516832 hasConcept C2986817661 @default.
• W3000516832 hasConcept C62746215 @default.
• W3000516832 hasConcept C71924100 @default.
• W3000516832 hasConcept C8243546 @default.
• W3000516832 hasConcept C99454951 @default.
• W3000516832 hasConceptScore W3000516832C126322002 @default.
• W3000516832 hasConceptScore W3000516832C134018914 @default.
• W3000516832 hasConceptScore W3000516832C142724271 @default.
• W3000516832 hasConceptScore W3000516832C204787440 @default.
• W3000516832 hasConceptScore W3000516832C27081682 @default.
• W3000516832 hasConceptScore W3000516832C2777457466 @default.
• W3000516832 hasConceptScore W3000516832C2778163477 @default.
• W3000516832 hasConceptScore W3000516832C2778562196 @default.
• W3000516832 hasConceptScore W3000516832C2780072125 @default.
• W3000516832 hasConceptScore W3000516832C2780541478 @default.
• W3000516832 hasConceptScore W3000516832C2780835420 @default.
• W3000516832 hasConceptScore W3000516832C2781039349 @default.
• W3000516832 hasConceptScore W3000516832C2908647359 @default.
• W3000516832 hasConceptScore W3000516832C2986817661 @default.
• W3000516832 hasConceptScore W3000516832C62746215 @default.
• W3000516832 hasConceptScore W3000516832C71924100 @default.
• W3000516832 hasConceptScore W3000516832C8243546 @default.
• W3000516832 hasConceptScore W3000516832C99454951 @default.
• W3000516832 hasIssue "4" @default.
• W3000516832 hasLocation W30005168321 @default.
• W3000516832 hasLocation W30005168322 @default.
• W3000516832 hasOpenAccess W3000516832 @default.
• W3000516832 hasPrimaryLocation W30005168321 @default.
• W3000516832 hasRelatedWork W1938181543 @default.
• W3000516832 hasRelatedWork W1973325649 @default.
• W3000516832 hasRelatedWork W1976602105 @default.
• W3000516832 hasRelatedWork W2025648868 @default.
• W3000516832 hasRelatedWork W2047447855 @default.

• next